Want to see HK:6618 full AI Analyst Report?
JD Health International, Inc. (6618) Ratios
JD Health International, Inc. Ratios
HK:6618's free cash flow for Q2 2026 was $4.37B. For the 2026 fiscal year, HK:6618's free cash flow was decreased by $-90.61M and operating cash flow was $4.46B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.72 | 3.77 | 3.28 | 3.45 | 5.71 |
| Quick Ratio | 2.37 | 3.39 | 2.93 | 3.08 | 5.33 |
| Cash Ratio | 1.53 | 1.46 | 1.03 | 1.14 | 2.16 |
| Solvency Ratio | 0.26 | 0.27 | 0.16 | 0.03 | -0.12 |
| Operating Cash Flow Ratio | 0.48 | 0.28 | 0.32 | 0.36 | 0.43 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 34.85B | $ 42.43B | $ 32.93B | $ 39.95B | $ 37.56B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.36 | 1.29 | 1.30 | 1.37 | 1.20 |
| Debt Service Coverage Ratio | 307.72 | 82.40 | 250.90 | -41.05 | -257.20 |
| Interest Coverage Ratio | 342.22 | 141.92 | 73.88 | -15.95 | -234.05 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.20 | 0.08 | 0.07 | 0.07 | 0.07 |
| Net Debt to EBITDA | -7.64 | -17.01 | -5.06 | 303.92 | 12.43 |
| Profitability Margins | |||||
| Gross Profit Margin | 24.78% | 22.88% | 22.17% | 21.16% | 23.46% |
| EBIT Margin | 5.17% | 2.00% | 5.05% | 1.51% | -2.92% |
| EBITDA Margin | 5.55% | 2.26% | 5.47% | -0.13% | -4.47% |
| Operating Profit Margin | 5.17% | 2.00% | 1.31% | -0.31% | -4.58% |
| Pretax Profit Margin | 8.21% | 8.25% | 5.03% | 1.49% | -2.94% |
| Net Profit Margin | 7.32% | 7.16% | 4.00% | 0.81% | -3.50% |
| Continuous Operations Profit Margin | 7.31% | 7.15% | 4.00% | 0.82% | -3.50% |
| Net Income Per EBT | 89.14% | 86.77% | 79.52% | 54.63% | 119.08% |
| EBT Per EBIT | 158.77% | 412.47% | 384.38% | -479.47% | 64.21% |
| Return on Assets (ROA) | 6.59% | 5.84% | 3.33% | 0.62% | -2.24% |
| Return on Equity (ROE) | 8.94% | 7.54% | 4.34% | 0.85% | -2.69% |
| Return on Capital Employed (ROCE) | 6.24% | 2.09% | 1.41% | -0.32% | -3.51% |
| Return on Invested Capital (ROIC) | 5.53% | 1.80% | 1.12% | -0.18% | -3.59% |
| Return on Tangible Assets | 6.75% | 6.02% | 3.45% | 0.64% | -2.24% |
| Earnings Yield | 3.37% | 5.00% | 1.96% | 0.19% | -0.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 168.25 | 103.94 | 75.74 | 35.92 | 75.63 |
| Payables Turnover | 4.18 | 4.30 | 4.31 | 3.50 | 4.28 |
| Inventory Turnover | 7.58 | 7.68 | 8.19 | 6.14 | 7.72 |
| Fixed Asset Turnover | 59.67 | 72.39 | 185.87 | 185.53 | 117.66 |
| Asset Turnover | 0.90 | 0.82 | 0.83 | 0.76 | 0.64 |
| Working Capital Turnover Ratio | 1.87 | 1.53 | 1.46 | 1.20 | 0.81 |
| Cash Conversion Cycle | -36.98 | -33.77 | -35.27 | -34.71 | -33.16 |
| Days of Sales Outstanding | 2.17 | 3.51 | 4.82 | 10.16 | 4.83 |
| Days of Inventory Outstanding | 48.17 | 47.55 | 44.54 | 59.40 | 47.27 |
| Days of Payables Outstanding | 87.32 | 84.82 | 84.63 | 104.28 | 85.25 |
| Operating Cycle | 50.34 | 51.06 | 49.36 | 69.56 | 52.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.11 | 1.37 | 1.46 | 1.90 | 1.11 |
| Free Cash Flow Per Share | 3.05 | 1.36 | 1.44 | 1.89 | 0.95 |
| Dividend Paid and CapEx Coverage Ratio | 67.55 | 93.46 | 66.42 | 147.04 | 6.83 |
| Capital Expenditure Coverage Ratio | 67.55 | 93.46 | 66.42 | 147.04 | 6.83 |
| Operating Cash Flow Coverage Ratio | 15.62 | 16.77 | 21.44 | 29.61 | 17.05 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.07 | 0.09 | 0.13 | 0.11 |
| Free Cash Flow Yield | 6.12% | 5.15% | 4.16% | 3.00% | 1.88% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 29.67 | 19.99 | 50.90 | 514.97 | -145.10 |
| Price-to-Sales (P/S) Ratio | 2.17 | 1.43 | 2.04 | 4.19 | 5.08 |
| Price-to-Book (P/B) Ratio | 2.65 | 1.51 | 2.21 | 4.37 | 3.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.34 | 19.41 | 24.04 | 33.37 | 53.19 |
| Price-to-Operating Cash Flow Ratio | 16.04 | 19.21 | 23.68 | 33.15 | 45.40 |
| Price-to-Earnings Growth (PEG) Ratio | 1.09 | 0.21 | 0.11 | -3.83 | 1.52 |
| Enterprise Value Multiple | 31.43 | 46.27 | 32.15 | -2908.62 | -101.13 |
| Enterprise Value | 128.16B | 60.84B | 94.20B | 177.23B | 138.71B |
| EV to EBITDA | 31.43 | 46.27 | 32.15 | -2908.62 | -101.13 |
| EV to Sales | 1.75 | 1.05 | 1.76 | 3.79 | 4.52 |
| EV to Free Cash Flow | 13.14 | 14.19 | 20.77 | 30.22 | 47.37 |
| EV to Operating Cash Flow | 12.90 | 14.04 | 20.46 | 30.01 | 40.43 |
| Tangible Book Value Per Share | 18.20 | 16.86 | 14.98 | 13.68 | 12.87 |
| Shareholders’ Equity Per Share | 18.80 | 17.52 | 15.67 | 14.41 | 12.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.11 | 0.13 | 0.20 | 0.45 | -0.19 |
| Revenue Per Share | 22.98 | 18.45 | 16.99 | 15.04 | 9.91 |
| Net Income Per Share | 1.68 | 1.32 | 0.68 | 0.12 | -0.35 |
| Tax Burden | 0.89 | 0.87 | 0.80 | 0.55 | 1.19 |
| Interest Burden | 1.59 | 4.12 | 1.00 | 0.99 | 1.01 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| SG&A to Revenue | 0.07 | 0.08 | 0.04 | 0.05 | 0.08 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.03 | 0.05 | 0.08 |
| Income Quality | 1.85 | 1.04 | 2.15 | 15.54 | -3.20 |
Currency in CNY